This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.
Device | P200039S005 |
Classification Name | None |
Applicant | |
PMA | P200039 |
Supplement | S005 |
Supplement Number | Date | Supplement Type |
---|---|---|
P200039 | Original Filing | |
S009 | 2022-12-08 | Normal 180 Day Track No User Fee |
S008 | 2022-10-11 | Real-time Process |
S007 | 2022-06-03 | Real-time Process |
S006 | 2021-12-22 | Real-time Process |
S005 | ||
S004 | 2021-10-22 | Real-time Process |
S003 | 2021-07-01 | 30-day Notice |
S002 | 2021-03-11 | Normal 180 Day Track No User Fee |
S001 | 2021-03-10 | Normal 180 Day Track No User Fee |
Device ID | PMA | Supp |
---|---|---|
00195451000119 | P200039 | 000 |
00195451000102 | P200039 | 000 |
00195451000096 | P200039 | 000 |
00195451000089 | P200039 | 000 |
00195451000034 | P200039 | 008 |
00195451000027 | P200039 | 008 |
00195451000010 | P200039 | 008 |
00195451000003 | P200039 | 008 |